HSE to extend Soliris drug to PNH & aHUS patients – Deering
4th February 2015 - Fine Gael Press Office
Fine Gael Carlow/ Kilkenny TD, Pat Deering, has today (Wednesday) welcomed confirmation from the HSE that they are to extend access to the drug Eculizumab (trading as Soliris), for patients with the conditions Paroxysmal Nocturnal Hemoglobinuria (PNH) and atypical Haemolytic Uraemic (aHUS).
“I have been advocating for this drug to be State funded ever since I heard the story of Ballinakill woman Mary Gorman who has PNH, a very rare and debilitating disease.
Related news
Social media companies must prevent sale of illicit tobacco products – McCarthy
Revenue needs to work closely with social media companies and Coimisiún na Meán to prevent the advertising and sale of…
2nd March 2025Micheál Carrigy TD elected Chair of Fine Gael Parliamentary Party
Deputy Micheál Carrigy has been elected as the new Chairperson of the Fine Gael parliamentary party. The Longford-Westmeath TD was…
26th February 2025Fine Gael nominates Mairead McGuinness to become Vice-President of the EPP
Tonight, Tánaiste and Leader of Fine Gael, Simon Harris T.D. announced that Fine Gael has nominated former EU Commissioner and…
26th February 2025